ALPS ETF Trust has released its latest financial report through an NPORT-P filing, providing insights into its asset management strategies and financial health. The report is significant as it showcases the company's total assets and liabilities, reflecting its standing in the competitive investment landscape.
As of August 31, 2026, ALPS ETF Trust reported total assets of approximately $843.4 million and total liabilities of about $354,309. The net assets amounted to around $843.1 million, indicating a strong financial position for the investment firm.
Background
ALPS ETF Trust, identified under the Central Index Key (CIK) 0001414040, operates in the investment sector. The company focuses on managing exchange-traded funds (ETFs) and is registered under the SEC file number 811-22175. The latest filing was made on October 29, 2026, and is part of a series of recent filings, all dated the same day, including multiple NPORT-P submissions.
What the Filing Says
The NPORT-P filing details the financial metrics of ALPS ETF Trust, stating, "The total assets are $843,421,371.11, and total liabilities are $354,309.49." This information is crucial for stakeholders and investors monitoring the fund's performance and operational efficiency.
Impact
This financial update may affect various stakeholders, including investors, financial analysts, and competitors in the ETF market. The reported figures can influence investor confidence and decisions regarding asset allocation in similar funds. As ALPS ETF Trust continues to navigate the investment landscape, other firms may look to adjust their strategies in response to these financial insights.
What's Next
The filing does not say what happens next. However, the ongoing monitoring of ALPS ETF Trust's performance will be essential for stakeholders as they evaluate future investment opportunities.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






